Akero Therapeutics Inc.
(AKRO) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
27.11
-1.92%
Pre-market Jan 07, 2025, 06:44 AM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Cash & Equivalents | 234.21M | 249.77M | 150.48M | 187.24M | 136.40M | 75.97M | 598.00K |
Short-Term Investments | 315.80M | 101.68M | 37.77M | 81.14M | 71.61M | n/a | n/a |
Long-Term Investments | 19.28M | n/a | n/a | 40.00K | 40.00K | 20.00K | 20.00K |
Other Long-Term Assets | n/a | 108.00K | 417.00K | 161.00K | 29.00K | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 9.95M | 7.45M | 10.65M | 5.92M | 3.30M | 2.31M | 80.00K |
Total Current Assets | 559.96M | 355.17M | 193.58M | 271.35M | 138.05M | 77.13M | 638.00K |
Property-Plant & Equipment | 1.03M | 1.29M | 1.55M | 1.79M | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 20.31M | 1.40M | 1.97M | 1.99M | 69.00K | 20.00K | 20.00K |
Total Assets | 580.27M | 356.57M | 195.55M | 273.34M | 138.12M | 77.15M | 658.00K |
Account Payables | 7.04M | 7.97M | 6.71M | 3.43M | 947.00K | 1.37M | 60.00K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 522.00K | 325.00K | 205.00K | 294.00K | 85.00K | n/a | n/a |
Other Current Liabilities | 11.57M | 10.79M | 18.22M | 9.39M | 8.34M | 969.00K | 162.00K |
Total Current Liabilities | 19.13M | 19.08M | 25.13M | 13.11M | 9.37M | 2.34M | 222.00K |
Long-Term Debt | 25.78M | 10.62M | 2.62M | 3.03M | n/a | n/a | n/a |
Other Long-Term Liabilities | 54.00K | 305.00K | -1.31M | -1.52M | 23.00K | 124.73M | 5.00M |
Total Long-Term Liabilities | 25.84M | 10.93M | 1.31M | 1.52M | 23.00K | 124.73M | 5.00M |
Total Liabilities | 44.97M | 30.01M | 26.44M | 14.63M | 9.39M | 127.07M | 5.22M |
Total Debt | 26.30M | 10.95M | 1.52M | 1.81M | n/a | n/a | n/a |
Common Stock | 6.00K | 5.00K | 4.00K | 4.00K | 3.00K | n/a | n/a |
Retained Earnings | -574.10M | -422.34M | -310.30M | -209.53M | -130.32M | -86.56M | -4.56M |
Comprehensive Income | 270.00K | 37.00K | -27.00K | -3.00K | -6.00K | n/a | n/a |
Shareholders Equity | 535.31M | 326.56M | 169.11M | 258.71M | 128.73M | -49.92M | -4.56M |
Total Investments | 335.09M | 101.68M | 37.77M | 81.14M | 71.61M | 20.00K | 20.00K |